Personalised insoles via additive manufacture for the prevention of plantar ulceration in diabetes

Projektinformationen

D-FOOTPRINT

ID Finanzhilfevereinbarung: 329133

Abgeschlossenes Projekt

Startdatum 14 Oktober 2013

Enddatum 13 Oktober 2015

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 196 682,10

EU-Beitrag € 196 682,10

Koordiniert durch

THE GLASGOW CALEDONIAN UNIVERSITY
United Kingdom

Ziel

Foot ulceration in patients with diabetes remains a highly prevalent, debilitating and expensive to treat problem. Recent recommendations by the International Working Group on the Diabetic Foot have suggested that therapeutic footwear including a custom insole should be the preferred intervention for those individuals who have been identified as “at risk” of developing a foot ulcer [1]. However, current methods for the design and fabrication of custom insoles limit the potential to incorporate innovations that could increase the effectiveness of these devices, primarily due to the geometric restrictions inherent to the methods.

The overall aim of this 24 month project is to develop, evaluate and disseminate a novel prescription paradigm, focused on additive manufacturing (AM) and biomechanical modelling enabled design rules, for insoles aimed at preventing or treating plantar surface ulceration in the diabetic foot. To achieve this, the latest biomechanical modelling approaches will be combined with AM technologies to develop novel prototype orthotic devices which are personalised to maximise benefit to the patient. A thorough program of pre-clinical and clinical evaluation will be established to test these devices, focused on assessing biomechanical and short term patient reported outcomes. This work program builds upon the successful research and technology developments in the EC-funded A-FOOTPRINT project (Grant Agreement no.: NMP2-SE-2009-228893), advancing integration of AM into the orthotic prescription process to a new and previously untried but highly relevant disease group.

The research will result in 1) a fundamental paradigm shift from subtraction (milling) to additive manufacturing, 2) step-change advances in personalised orthotic design optimisation, and 3) a new therapeutic option for a debilitating and expensive European and worldwide health problem

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › endocrinology › diabetes
• engineering and technology › mechanical engineering › manufacturing engineering › additive manufacturing
• engineering and technology › medical engineering › wearable medical technology

Programm/Programme

• FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Thema/Themen

• FP7-PEOPLE-2012-IOF - Marie Curie Action: "International Outgoing Fellowships for Career Development"

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2012-IOF
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

MC-IOF - International Outgoing Fellowships (IOF)

Koordinator

THE GLASGOW CALEDONIAN UNIVERSITY

Kontakt Verwaltung

Mark Anderson (Mr.)

• EU-Beitrag: € 196 682,10
• Adresse: Cowcaddens Road, City Campus 70 ; G4 0BA Glasgow ; Vereinigtes Königreich
• Region: Scotland › West Central Scotland › Glasgow City
• Aktivitätstyp: Higher or Secondary Education Establishments
• Gesamtkosten: Keine Daten